Explanted Device Disposition

Lawrence Poree, MD MPH PhD (chair)

Joseph J. Fins, MD MACP FRCP (ethics)

Henry T. "Hank" Greely, MD (ethics)

Michael Sanchez (patient advocate)

Ellen Doneski (legal/liability/regulatory affairs)

John Doucet, PhD (legal/liability/regulatory affairs)

Pierre D'Haese, PhD (data security)

Ashwini Sharan, MD FACS

Robert Foreman, FAHA PhD

Jaimie Henderson, MD

Peter Konrad, MD PhD

Richard North, MD

Kiran V. Patel, MD

David A. Provenzano, MD

Ali Rezai, MD

Sarah Staples, MA ELS

Corporate Partners

Andrea Morrison (Abbott)

Rita Bojalian (Boston Scientific)

Mona Patel (Boston Scientific)

Sam Tahmasian (Boston Scientific)

Lauren Ciccarelli, MS (Exponent)

Autumn Bullard, PhD (Exponent)

Mariana Garcia, PhD PMP (Exponent)

Steven M. Kurtz, PhD (Exponent)

Nikita Pak, PhD (Exponent)

Felicia L. Svedlund, PhD (Exponent)

Robert Gaskill (Medtronic)

Mark Gryzwa (Medtronic)

Marshall Stanton, MD (Medtronic)

Huzefa Mamoola (Nevro)

Gregory Fiore, MD (Sollis Therapeutics)

The project members created a device disposition survey, which has been sent out to the NANS membership.

Our next meetings will work on further clarification of the types of testing that may be needed and the liability/regulatory consequence of such testing. This committee is dependent on and thankful for the participation of our academic ethicists, patient advocates, industry engineers and legal counsel, as well as our government regulatory consultants.